Sashelp Data Sets - SAS Support

027-2009: Tips and Tricks for Creating the Reports …

Paper 027-2009 TIPS AND TRICKS FOR CREATING THE REPORTS YOUR CLIENTS NEED TO SEE Michael J Molter, INC Research, Raleigh, NC ABSTRACT Advanced reporting tools such as PROC REPORT have progressed by leaps and …

  Your, Report, Creating, Tricks for creating the reports, Tricks, Tricks for creating the reports your clients, Clients

Step-by-Step Programming with Base SAS Software

The correct bibliographic citation for this manual is as follows: SAS Institute Inc. 2001. Step-by-Step Programming with Base SAS® Software.Cary, NC: SAS Institute Inc.

  Programming, With, Base, Step, Software, By step programming with base sas software, By step programming with base sas, 174 software

227-2012: Executing a PROC from a DATA Step - …

2 Using RUN_MACRO to execute a PROC from a DATA step requires writing three blocks of code, described in the Introduction: a macro to execute a PROC, a user-written function to execute the macro, and a DATA step to call the

  Form, Introduction, Step, Corps, 2012, Executing a proc from a, Executing

149-2012: Queries, Joins, and WHERE Clauses, Oh …

Paper 149-2012 Queries, Joins, and WHERE Clauses, Oh My!! Demystifying PROC SQL Christianna S. Williams, Chapel Hill, NC ABSTRACT Subqueries, inner joins, outer joins, HAVING expressions, set operators…just the terminology of PROC SQL might

  Where, Corps, Queries, Joins, And where clauses, Clauses

158-2010: How to Use Arrays and DO Loops: Do I …

1 Paper 158-2010 How to Use ARRAYs and DO Loops: Do I DO OVER or Do I DO i? Jennifer L Waller, Medical College of Georgia, Augusta, GA ABSTRACT

  Array, Loops, Use arrays and do loops

248-2009: Learning When to Be Discrete: …

1 Paper 248–2009 Learning When to Be Discrete: Continuous vs. Categorical Predictors David J. Pasta, ICON Clinical Research, San Francisco, CA ABSTRACT

  Discrete, Continuous, Continuous vs, Categorical predictors, Categorical, Predictors

338-2011: An Introduction to Survival Analysis …

2 (Censored) Study Ends (From Applied Survey Data Analysis, p. 306) Figure 1. Prospective View of Event History Survey Data Time can be regarded as continuous or discrete and this basic distinction affects the analytic approach selected.

  Analysis, Introduction, Survival, Continuous, An introduction to survival analysis

Dongsheng Yang and Jarrod E. Dalton - SAS

1 Paper 335-2012 A unified approach to measuring the effect size between two groups using SAS® Dongsheng Yang and Jarrod E. Dalton Departments of Quantitative Health Sciences and Outcomes Research

  Yang, Dongsheng yang and jarrod e, Dongsheng, Jarrod

SAS/STAT 9.2 User's Guide: Introduction to Power …

SAS/STAT ® 9.2 User’s Guide Introduction to Power and Sample Size Analysis (Book Excerpt) SAS® Documentation

  Analysis, Introduction, Power, Samples, Book, Size, Introduction to power and sample size analysis, Book excerpt, Excerpt

249-2012: A Tutorial on the SAS® Macro Language

1 Paper 249-2012 A Tutorial on the SAS® Macro Language John J. Cohen, Advanced Data Concepts LLC, Newark, DE ABSTRACT The SAS macro language is another language layering on top of regular SAS code.

  Language, Macro, Tutorials, Tutorial on the sas, 174 macro language, Sas macro

427-2013: Creating and Customizing the Kaplan-Meier ...

in one of three risk categories: ALL (acute lymphoblastic leukemia), AML (acute myelocytic leukemia)—Low-Risk, and AML—High-Risk. The endpoint of interest is the disease-free survival time, which is the time in days until death, relapse, or the end of the study.

  Kaplan, Meier, Lymphoblastic, Kaplan meier

National Cancer Institute Children with Cancer

acute lymphoblastic leukemia (ALL) acute myeloid leukemia (AML) Lymphoma. starts in the lymphatic system, which is part of the body’s . immune system. There are several types: Hodgkin lymphoma non-Hodgkin lymphoma. Neuroblastoma. forms in nerve tissue in the neck, spinal cord, or adrenal gland. Sarcoma

  With, National, Institute, Children, Cancer, Lymphoblastic, National cancer institute children with cancer

Commissioning Criteria Policy for the use of therapeutic ...

acute lymphoblastic leukaemia (B-ALL) Because of the severity of B-cell aplasia and the longer time required for reconstitution, it is anticipated that virtually all patients (children and adults) with B-ALL will initially require Ig replacement following CAR-T cell therapy. As with the use of Ig post-CAR-T therapy in B-cell lymphoma, continued

  Lymphoblastic

Creating and Customizing the Kaplan-Meier Survival Plot in ...

each patient is classified in one of three risk categories: ALL (acute lymphoblastic leukemia), AML (acute myelocytic leukemia)–Low Risk, and AML–High Risk. The endpoint of interest is the disease-free survival time, which is the time in days until death, relapse, or the end of the study. The variable Group represents

  Lymphoblastic

ブリナツモマブ（AMG 103 MT 103 又は ）は、二重特異性 T …

ALL Acute lymphoblastic leukemia（急性リンパ性白血病） AMG 103 Blinatumomab（ブリナツモマブ） ANOVA Analysis of Variance（分散分析） B-ALL B-cell acute lymphocytic leukemia（B 細胞性急性リンパ性白血病） B-CLL B-cell chronic lymphocytic leukemia（B 細胞性慢性リンパ性 …

  Lymphoblastic

悪性リンパ腫 （低悪性度） - harasanshin.or.jp

悪性リンパ腫の分類ごとの頻度 A) Malignant lymphoma (n=933) 1B cell lymphoma471(50%) 2T/NK cell lymphoma396(42%) 3Hodgkin's diseae41(4%)